High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.

Creative Commons License

Celebioglu B. , Gurkan O., Erdogan S., Savas I., Kose K., Kurtman C., ...More

Japanese journal of clinical oncology, vol.32, no.11, pp.443-8, 2002 (Journal Indexed in SCI Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 11
  • Publication Date: 2002
  • Doi Number: 10.1093/jjco/hyf102
  • Title of Journal : Japanese journal of clinical oncology
  • Page Numbers: pp.443-8


Background: Intraluminal brachytherapy has become an established treatment for major airway occlusion by relapsed or persistent inoperable endobronchial tumors. The aim of this study was to compare the palliation improvement pre- and post-radiotherapy.